| Literature DB >> 35197685 |
Nikita Naredi1, Rajesh Sharma2, Pranay Gurmeet3.
Abstract
BACKGROUND: Evaluation of uterine cavity is an important step during investigation of infertile women. The presence of uterine pathology causes impaired receptivity, failed implantation and poor pregnancy outcomes. Various investigative modalities though available; have their limitations. Hysteroscopy considered the gold standard diagnostic modality is invasive; thus, an investigation which could overcome its limitations was required. 3-Dimensional transvaginal sonography (3D TVS), which non-invasively visualizes uterine morphology, registers all three imaging planes simultaneously could be an alternative to hysteroscopy. AIM: To compare 3-D TVS with the gold standard office hysteroscopy for evaluating uterine cavity in sub fertile women. SETTING ANDEntities:
Keywords: Three-dimensional transvaginal sonography; hysteroscopy; intrauterine abnormalities
Year: 2021 PMID: 35197685 PMCID: PMC8812396 DOI: 10.4103/jhrs.jhrs_97_21
Source DB: PubMed Journal: J Hum Reprod Sci ISSN: 1998-4766
Figure 1A mid-longitudinal (sagittal) section of the uterus in two dimensional with the region of interest adjusted for optimal acquisition of three-dimensional volume. The rendered image obtained by adjusting the rendering box containing the region of interest in Window A to include the uterine fundus
Figure 2(a) Endometrial polyp as diagnosed by two-dimensional transvaginal sonography; (b) three-dimensional transvaginal sonography and on hysteroscopy; (c) Endometrial polyp
Figure 3Two-dimensional and three-dimensional and hysteroscopic image of a unicornuate uterus
Figure 4(a and b) Septation as seen on hysteroscopy. (c) Uterine septation
Demographic characteristics of the study subjects (n=154)
| Characteristic | Mean±SD |
|---|---|
| Age (years) | 27.8±3.7 |
| BMI (kg/m2) | 24.97±4.48 |
| Duration of infertility (years) | 5.5±3.1 |
| Hormonal profile | |
| LH (IU/L) | 5.58±3.71 |
| FSH (IU/L) | 6.24±2.88 |
| AMH (ng/ml) | 4.73±3.96 |
SD: Standard deviation, BMI: Body mass index, LH: Luteinising hormone, FSH: Follicle-stimulating hormone, AMH: Anti-Mullerian hormone
Cause of infertility in the study group
| Cause | Frequency |
|---|---|
| PCOS | 36 |
| PCOS + tubal factor | 5 |
| PCOS + uterine factors | 4 |
| Combined (male + female factors) | 25 |
| Tubal factor | 15 |
| Unexplained | 23 |
| DOR | 13 |
| Male factor | 12 |
| Endometriosis | 6 |
| Endometriosis + tubal factor | 6 |
| Endometriosis + PCOS | 4 |
| Uterine factor | 4 |
| Cervical | 1 |
PCOS: Polycystic ovarian syndrome, DOR: Decreased ovarian reserve
Findings of three-dimensional transvaginal sonography and hysteroscopy
| Finding | 3D TVS ( | Hysteroscopy ( |
|---|---|---|
| Normal | 130 | 128 |
| Adhesion | 1 | 2 |
| Asherman’s syndrome | 1 | 1 |
| Unicornuate uterus | 2 | 3 |
| Bicornuate uterus | 4 | 0 |
| Arcuate uterus | 3 | 3 |
| Polyp | 7 | 6 |
| Septate | 6 | 10 |
| Periosteal fibrosis | 0 | 1 |
3D TVS: three-dimensional transvaginal sonography
Comparison of three-dimensional transvaginal sonography with hysteroscopy
| 3D USG | Office hysteroscopy | Total | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|
|
| |||||
| + | − | ||||
| + | 23 | 1 | 24 | 88.46 | 99.21 |
| − | 3 | 127 | 130 | ||
| Total | 26 | 128 | 154 | ||
Positive predictive value: 95.83%, Negative predictive value: 97.69%, Diagnostic accuracy: 97.4%. 3D USG: 3D ultrasonography. +: Uterine abnormality detected. -: Uterine abnormality not detected